Sign inJoin waitlistJoin the waitlist

DW

Ding Wang

Physician · Henry Ford Health

Credentials: ·

History

Henry Ford Health
2019–Present

Hematology and Medical Oncology
1986–1989
Internal Medicine
1983–1986
Medical School
1979–1983

Research

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
Journal of Clinical Oncology · 2017 · 485 citations
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial
The Lancet Oncology · 2018 · 469 citations
Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study
The Lancet Oncology · 2020 · 407 citations

KK
Karen Kelly
6 papers
James Gulley
5 papers
Manish Patel
5 papers
Patricia LoRusso
5 papers
Afshin Dowlati
3 papers
Andrea Apolo
3 papers
Dale Shepard
3 papers
JI
Jeffrey Infante
3 papers
Michael Gordon
3 papers
AG
Arnold Gelb
2 papers
CB
Carolyn Britten
2 papers
Crystal Denlinger
2 papers